Divis Laboratories Q2 Results
- BSE: 532488
- NSE: DIVISLAB
- ISIN: INE361B01024
- Sector: Biotechnology & Drugs
BSE
6,715.00
-70.40 (-1.04%)
-70.40 (-1.04%)Volume1.72 K
Updated: Fri 18 Jul, 2025 | 15:29:42
NSE
6,731.50-59.00 (-0.87%)
-59.00 (-0.87%)Volume1.97 L
Updated: Fri 18 Jul, 2025 | 15:40:10
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Divis Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 1,721.00 | 1,593.00 | 8.04% |
| Depreciation/ Amortization | 99.00 | 97.00 | 2.06% |
| Operating Income | 617.00 | 525.00 | 17.52% |
| Net Income | 510.00 | 430.00 | 18.60% |
| Other Operating Expenses Total | 349.00 | 351.00 | -0.57% |
| Net Income Before Taxes | 722.00 | 604.00 | 19.54% |
| Total Revenue | 2,338.00 | 2,118.00 | 10.39% |
| Selling/ General/ Admin Expenses Total | 304.00 | 292.00 | 4.11% |
| Diluted Normalized EPS | 19.20 | 16.20 | 18.52% |